The 36-Year-Old Who Wants 'The Strongest Scan' Before Pregnancy
Ms. R is 36, Ashkenazi Jewish, and the daughter of a woman diagnosed with triple-negative breast cancer at 41 who later tested positive for a BRCA1 pathogenic variant. Ms. R declined genetic testing two years ago because of cost and never returned to discuss it. She has never had a mammogram. Her sister, 39, was diagnosed with stage I breast cancer last month and has not had tumor testing. Ms. R's breast exam today is normal with no complaints. She asks for 'the strongest scan available' and wants to know whether to have risk-reducing mastectomy before she and her partner start trying to conceive this year. She is insured through a high-deductible plan with a $4,000 deductible and limited out-of-network benefits.
1. Before any imaging is ordered, what risk assessment steps are indicated, and how do you respond to her request for 'the strongest scan available'?
Read the worked answer
Genetic risk evaluation is the highest-yield next step, not imaging. Ms. R is a first-degree relative of a known BRCA1 carrier, so her pretest probability of carrying the variant is roughly 50 percent. Testing her is what converts an assumption into a management plan, and it also determines what her sister's tumor testing should include. Cost is the stated barrier, so the visit should include concrete workarounds: laboratory self-pay pricing, manufacturer and foundation assistance programs, and a social work referral, all documented before she declines again.
There is no single 'strongest scan.' For a high-risk woman, screening is annual contrast-enhanced MRI plus annual mammography, staggered about six months apart, because MRI is more sensitive but misses microcalcifications that mammography detects. Ordering MRI on the basis of anxiety or dense breasts alone is not indicated and can generate false positives that delay her plans.
If testing is completed or still pending but she is managed as high risk, high-risk surveillance begins now at age 36 rather than waiting for a mammogram at 40.
2. She declines genetic testing again after counseling. What surveillance plan can you defend, and what must be documented?
Read the worked answer
NCCN guidance supports managing an untested first-degree relative of a known BRCA carrier as high risk, so a defensible plan is annual mammography plus annual breast MRI staggered six months apart, starting now, with clinical breast exam every 6 to 12 months. Also offer a conversation about risk-reducing mastectomy as a legitimate option rather than presenting surveillance as the only path.
Documentation should state that genetic counseling was provided twice, that testing was declined, and that the estimated lifetime risk and the rationale for high-risk surveillance were explained in plain language. Record the cost barriers identified and the referrals made. Note that the plan assumes she carries the family variant and that the estimate changes if she is later tested.
The nurse's judgment point is that declining a test does not mean downgrading her to average-risk screening; it means acting on the family history while keeping the door open. Schedule a documented re-discussion at each annual visit and involve her sister in conversations about tumor testing, since a known familial variant makes testing more informative.
3. She asks whether to have risk-reducing mastectomy now or after pregnancy. How do you frame the decision?
Read the worked answer
Frame it as a preference-sensitive decision with no single correct answer, then lay out the tradeoffs. Risk-reducing mastectomy reduces breast cancer incidence by roughly 90 to 95 percent in BRCA1 carriers but does not eliminate risk, and reconstruction is typically staged over months, which would delay conception. A one- to two-year delay in prophylactic surgery does not usually change her risk in a clinically meaningful way, but she should hear that from the surgical team rather than infer it.
If she chooses pregnancy first, surveillance must continue and be adapted: contrast-enhanced MRI is avoided during pregnancy and gadolinium is avoided during lactation, so the plan shifts toward ultrasound and clinical exam under the guidance of a breast radiologist. Lactation also makes imaging harder to interpret, which belongs in the discussion.
Coordinate with genetic counseling, breast surgery, and fertility or reproductive specialists, and consider oocyte or embryo cryopreservation before any risk-reducing surgery. Document that she understands the plan is time-limited and will be revisited after delivery or after she completes any lactation goals.